Board of Directors

Jón Sigurdsson

Chairman of the board

Born 1956. B.Sc. in Industrial Engineering, Master's degree in Business Administration (MBA). Board member since 2015. Member of Remuneration Committee.

Other assignments
President and CEO at Össur. Chairman of the Icelandic American Chamber of Commerce.

Previous assignments
Commercial Counselor for the Icelandic Trade Council in New York, CFO at Álafoss, Head of the International Division of Eimskip and Engineer for Bang and Olufsen Denmark.

Shareholding in Vitrolife*: 25,000 shares.

Henrik Blomquist

Born 1971. University studies in Business Administration.
Board member since 2019. Member of Audit Committee.

Other assignments

CEO of Bure Equity AB. Chairman of the board of Mercuri International Group AB, Investment AB Bure and Bure Growth AB. Board member in MedCap AB, Bure Financial Services AB and Atle Investment Services.

Previous assignments
Experience of investment operations and corporate development. Investment manager at Skanditek Industriförvaltning, analyst in ACR Venture Management.

Shareholding in Vitrolife*: 0 shares.


Barbro Fridén 

Born 1956. MD, PhD, Subspecialist in reproductive medicine/IVF. Board member since 2010. Chairman of Remuneration Committee.

Other assignments
Board member in Getinge AB, Apoteket AB, Helsa AB, Brighter AB and the Swedish Sea Rescue Society.

Previous assignments
CEO of Sheikh Khalifa Medical City Ajman, United Arab Emirates, CEO of Sahlgrenska University Hospital, Division Director for Astrid Lindgren's Children's Hospital, Director of Fertilitetscentrum AB in Göteborg and Stockholm and Medical Editor of Läkartidningen.

Shareholding in Vitrolife*: 850 shares.

Lars Holmqvist

Born 1959. MSc in Business Administration.
Board member since 2018. Member of Audit Committee.

Other assignments
Chairman of the board in Biovica International AB. Board member in the Lundbeck Foundation, H Lundbeck A/S, ALK-Abelló A/S, Tecan AG and BPL Plc-UK.

Previous assignments
Senior Advisor within healthcare at Bain Capital. Senior management positions in pharma and medtech companies including Agilent, Dako, Applied Biosystems Inc., Medtronic Europe Sarl, Boston Scientific Europe and Pharmacia.

Shareholding in Vitrolife*: 0 shares.

Pia Marions

Born 1963. M.Sc. in Business and Economics. Board member since 2013. Chairman of Audit Committee.

Other assignments
CFO of Skandia. Board member in Skandiabanken, Skandia Fastighet and Svenska Revisionsakademin.

Previous assignments
CFO of Folksam, CFO of Carnegie Group, senior positions at RBS (Royal Bank of Scotland), Skandia Liv, Länsförsäkringar Liv, Swedish Financial Supervisory Authority (Finansinspektionen) and has worked as certified public auditor.

Shareholding in Vitrolife*: 5,000 shares.

* including holdings of spouse, children and closely related companies